GermanyGermany

German government gives health research a big leg up

06.02.2011

Berlin – In the second major biotech-related funding project from the German Federal Ministry of Education and Research (BMBF) within two months, the ministry announced that Germany will be spending more than EUR5.5bn on a programme for health research by 2014. In December of last year, Research Minister Annette Schavan started a EUR2.4bn funding scheme for the bio-economy. The lion’s share from the most recent health research programme that is to be funded by the BMBF will be invested in six German Centers for Health Research. The aim is to help top scientists and researchers from both university medicine and non-academic facilities work together, and provide them with long term funding. “We are pursuing the strategy to bring together the best scientists and thereby promote the rapid transfer of knowledge from the laboratory into practice,” said Schavan. The German Centre for Neurodegenerative Diseases (DZNE) and the German Center for Diabetes Research have already begun work. The four other centres – for Infection, Lung Diseases, Cardiovascular Diseases and Cancer – were announced in December, and will begin work soon.

Germany, FranceGermany

21.12.2011

Martinsried/Paris - Sanofi has done some Christmas shopping in Munich and has licensed Scil Technology’s programme for the regenerative treatment of osteoarthritis and cartilage disorders. Under the agreement, Scil could reap up...

GermanyGermany

20.12.2011

Monheim - It's nearly Christmas, and Bayer Crop Science gives out some presents. As the company announced, a $750 million settlement with U.S. rice farmers is now binding and can move forward. In summer the German firm had agreed...

GermanyGermany

16.12.2011

Bonn – Germany’s federal government is prolonging one of its most successful measures to date for stimulating the establishment of high-tech companies – the High-Tech-Gründerfonds (HTGF). The HTGF was launched in 2005 with €272m...

GermanyGermany

15.12.2011

Leverkusen – One short statement from the European Medicines Agency (EMA) means one giant step for German biotech company Biofrontera. The agency issued a favourable opinion on the firm’s marketing approval application for its...

GermanyGermany

15.12.2011

While the European sovereign debt crisis keeps capital markets in a choke-hold, with potential negative effects on the financing situation in many industries – including biotech – there was encouraging news for drug-developing...

GermanyGermany

08.12.2011

Heidelberg – There is still life in the European life science finance. EMBL Ventures has closed a €40m fund. The early stage investor and the venture capital arm of the European Molecular Biology Laboratory(EMBL) announced the...

GermanyGermany

03.11.2011

Düsseldorf – BIO-Europe 2011 in Düsseldorf has again broken all previous records in terms of participants and company numbers. More than 3,000 representatives from 1,800 companies registered for Europe‘s largest partnering event....

GermanyGermany

02.11.2011

Brussels/San Francisco – As the biggest biotech partnering event on the continent, BioEurope, draws to a close, the venture capital community sent ambivalent messages for life sciences. Dow Jones VentureSource, an analyst,...

Displaying results 11 to 20 out of 454

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-germany/browse/1/article/german-government-gives-health-research-a-big-leg-up.html

Product of the week

Products

Events

All Events

Current issue

All issues